Abstract:Oral squamous cell carcinoma (OSCC), with aggressive locoregional invasion, has a high rate of early recurrences and poor prognosis. Dihydroartemisinin (DHA), as a derivative of artemisinin, has been found to exert potent antitumor activity. Recent studies reported that DHA suppresses OSCC cell growth and viability through the regulation of reactive oxygen species (ROS) production and mitochondrial calcium uniporter. However, the mechanism underlying the action of DHA on OSCCs remains elusive. In the study, we observed that 159 genes were remarkably misregulated in primary OSCC tumors associated with DHA-inhibited pathways, supporting that OSCCs are susceptible to DHA treatment. Herein, our study showed that DHA exhibited promising effects to suppress OSCC cell growth and survival, and single-cell colony formation. Interestingly, the combination of DHA and cisplatin (CDDP) significantly reduced the toxicity of CDDP treatment alone on human normal oral cells (NOK). Moreover, DHA remarkably impaired mitochondrial structure and function, and triggered DNA damage and ROS generation, and activation of mitophagy. In addition, DHA induced leakage of cytochrome C and apoptosis-inducing factor (AIF) from mitochondria, elevated Bax/cleaved-caspase 3 expression levels and compromised Bcl2 protein expression. In the OSCC tumor-xenograft mice model, DHA remarkably suppressed tumor growth and induced apoptosis of OSCCs in vivo. Intriguingly, a selective mitophagy inhibitor Mdivi-1 could significantly reinforce the anticancer activity of DHA treatment. DHA and Mdivi-1 can synergistically suppress OSCC cell proliferation and survival. These data uncover a previously unappreciated contribution of the mitochondria-associated pathway to the antitumor activity of DHA on OSCCs. Our study shed light on a new aspect of a DHA-based therapeutic strategy to combat OSCC tumors.

Anti-tumor Effect of DHA on Ovarian Cancer and its Mechanism

Inhibition of DHA on colorectal tumor pathogenesis and expression of related genes

Study on the Apoptosis of Gastric Cancer Cells SGC-7901 Induced by DHA and Its Mechanism

Docosahexaenoic Acid in the Inhibition of Tumor Cell Growth in Preclinical Models of Ovarian Cancer

THE ANTITUMOR MECHANISM OF SERUM AGAINST GROWTH INHIBITION OF DHA TO A549 LUNG CANCER CELLS

Dihydroartiminisin Inhibits the Growth and Metastasis of Epithelial Ovarian Cancer.

The omega-3 polyunsaturated fatty acid docosahexaenoic acid inhibits proliferation and progression of non-small cell lung cancer cells through the reactive oxygen species-mediated inactivation of the PI3K /Akt pathway

Dihydroartemisinin is an Inhibitor of Ovarian Cancer Cell Growth

The Effects of DHA Compound on Cell Cycle and Apoptos is of Both H22 Cell and T Cell in Mouse Bearing Tumor

Microarray analysis of anti-cancer effects of docosahexaenoic acid on human colon cancer model in nude mice.

Repurposing Dihydroartemisinin to Combat Oral Squamous Cell Carcinoma, Associated with Mitochondrial Dysfunction and Oxidative Stress

DHA2, a Synthesized Derivative of Bisbibenzyl, Exerts Antitumor Activity Against Ovarian Cancer Through Inhibition of XIAP and Akt/mTOR Pathway

Docosahexaenoic acid supresses breast cancer cell proliferation and migration by promoting the expression of miR-99a and targeting mTOR signaling

Effects of MAPKs Signaling Transduction Pathway on the DHA-induced Apoptosis of Gastric Cancer Cells

Dihydroartemisinin inhibited stem cell-like properties and enhanced oxaliplatin sensitivity of colorectal cancer via AKT/mTOR signaling.

Dihydroartemisinin Inhibits Angiogenesis In Pancreatic Cancer By Targeting The Nf-Kappa B Pathway

Dihydroartemisinin prevents breast cancer-induced osteolysis via inhibiting both breast caner cells and osteoclasts

Effects of DHA on Cell Proliferation and Apoptosis of Human Hepatocellular Carcinoma Cells

The Potential of DHA as Cancer Therapy Strategies: A Narrative Review of In Vitro Cytotoxicity Trials

Dihydroartemisinin Inhibits Growth of Pancreatic Cancer Cells in Vitro and in Vivo

Pronounced Enhancement in Radiosensitization of Esophagus Cancer Cultivated in Docosahexaenoic Acid via the PPAR - γ Activation